This is the authors' abstract. We don't add key points for this paper.
In the present study a new series of 3-hydroxy-7-isocyano-6-oxo-8-phenyl-2-(substitutedphenyl(piperidin-1-yl)methyl)-6H-thiazolo-[3′,2′:2,3][1,2,4]triazolo[1,5-a]-pyridine-9-carbonitrile (5a–j) and (Z)-2-(4-substitutedbenzylidene)-7-isocyano-3,6-dioxo-8-phenyl-3,6-dihydro-2H-thiazolo-[3′,2′:2,3][1,2,4]triazolo[1,5-a]pyridine-9-carbo-nitrile derivatives (4a–j) were synthesized. The newly synthesized compounds were characterized by IR, 1H NMR, LC–MS mass, and C, H, N analyses. All newly synthesized compounds were screened for their antibacterial (Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus pyogenes, and Klebsiella pneumoniae) and antifungal (Aspergillus flavus, Aspergillus fumigatus, Candida albicans, Penicillium marneffei and Trichophyton mentagrophytes) activity. The results revealed that all synthesized compounds have a significant biological activity against the tested microorganisms. Compounds 4a, 4f, 4i, 4j, 5a, 5i, and 5j exhibited good antimicrobial activity.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Suresh et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: